The difference between information and
expert, data-driven actionable intelligence

June 2015

Welcome to the June 2015 issue of CMC Market Outlook

This monthly e-newsletter provides valuable insights for both buyers and sellers of CMC drug development services. Our coverage will help you identify and understand market trends that will inform your strategic business perspective.

Enjoy the June issue!

The PharmSource Team

 

Pharma Industry Sees Increasing Capital Expenditures

Capital expenditure in new plant and equipment (capex) by the bio/pharmaceutical industry increased sharply in 2014. Total spend exceeded $21.4 billion, a 13% increase over 2013 and more than the 11% annual increase observed from 2010 through 2013.

Spending by the 25 largest global biopharma companies increased by 10.5% to $19.2 billion, while capex by the mid-size sector rose 46% to $2.2 billion in 2014.

It’s especially notable that… read on
 

How big is the market for…?

This is a handy guide to frequently requested data about the bio/pharma contract services industry.

How much is the bio/pharmaceutical industry spending on investment for new plant and equipment?

Market Size Source
2013: $18.6 billion total capex
2014: $21.4 billion total capex represents an increase of 13%
Bio/Pharmaceutical Outsourcing Report
Pharma Industry Sees Increasing Capital Expenditures
May 2015

Read more about the size of the contract services market for various segments.
 

Patheon Files for IPO

Patheon, one of the two largest CMOs in the bio/pharmaceutical industry, has filed a registration statement (S-1) with the US Securities and Exchange Commission for an initial public offering of its stock. No details on timing, price or number of shares have been provided as yet.

The S-1 reveals the transformation of Patheon since it went private in March 2014, integrated the assets of DSM Pharmaceutical Products, and… read on
 

PharmSource Strategic Advantage User Tip

Did you know you can do a subject search for topics of specific interest to quickly find related articles published by PharmSource in our Outsourcing Reports? To do this, select the Subject Search button in the left navigation bar of the Strategic Advantage Home page, then use the search box on the Archives page to enter a topic of interest. This will instantly provide direct links to all the articles PharmSource has published in Bio/Pharmaceutical Outsourcing Report and Emerging Markets Outsourcing Report that include the keywords you indicated.

You also can make a selection from the standard topic list on the Subject Search page. For example, you can click on Commercial Dose Manufacturing and receive a detailed list of articles on that topic.

For questions about this feature or any other inquiries regarding PharmSource Strategic Advantage, please contact our Director of Account Management, Blythe Moore, at +1.703.383.4903, ext. 104 | blythe.moore@pharmsource.com.
 

PharmSource STRATEGIC ADVANTAGE

Let PharmSource be your market intelligence guide.

PharmSource’s STRATEGIC ADVANTAGE service is the industry’s most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. Developed from PharmSource’s expert proprietary research, you won’t find this information in any other resource.

See for yourself how this resource gives you vital tools for understanding the industry.

To request a test-drive today, contact Nathaniel Celentano at nathaniel@pharmsouce.com / +1-703-383-4903, ext. 112 (ET USA).